Results 31 to 40 of about 1,536 (210)

Scleredema Associated With IgG/κ Monoclonal Gammopathy of Clinical Significance Successfully Treated With Daratumumab Monotherapy: A Case Report. [PDF]

EJHaem
ABSTRACT Background Cutaneous monoclonal gammopathy of clinical significance (MGCS) is rare and may present with scleredema‐like fibrosing skin disease. Case A 59‐year‐old man developed progressive induration of the upper body. Laboratory studies revealed an IgG/κ monoclonal protein, and skin biopsy showed dermal thickening with mucin deposition.
Marcolongo D, Bressan A, Zanatta E, Alaibac MSA, Gianesello I, Binotto G, Pavan L, Tos APD, Trentin L, Vianello F.   +9 more
europepmc   +2 more sources

Sclerosing diseases of the skin. [PDF]

J Dtsch Dermatol Ges
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Kalantari Y, Meier K, Ghoreschi K, Kinberger M, Solimani F.   +4 more
europepmc   +2 more sources

SARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema [PDF]

, 2021
Mike Fritz, Daniel Tinker, Alex W. Wessel, Gabriela M. Morris, Linda Goldenberg, Mark Fesler, Lokesh Rukmangadachar, M. Yadira Hurley   +7 more
openalex   +4 more sources

Discrete papular lichen myxedematosus successfully treated with isotretinoin [PDF]

JAAD Case Reports
Alexa Figueroa Baiges, BS, Nina Punyamurthy, MD, Alexander M. Maley, MD   +2 more
doaj   +2 more sources

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin [PDF]

JAAD Case Reports, 2023
Donglin Zhang, BA, Kimberly Sable, MD, Allison Miller, MD, Molly Hinshaw, MD, Timothy Schmidt, MD, Bridget E. Shields, MD   +5 more
doaj   +2 more sources

Hyalase in Dermatology: Applications Beyond Filler Management. [PDF]

J Cosmet Dermatol
ABSTRACT Background Hyaluronic acid (HA) is a key extracellular matrix component in the skin. Hyaluronidase is an enzyme that breaks down HA into monosaccharides. The FDA has approved this enzyme for hypodermoclysis, drug absorption enhancement, and subcutaneous urography.
Hasanzadeh S, Farokh P, Hosseini GS, Abbasian M, Etesami I, Zaresharifi S, Dadkhahfar S.   +6 more
europepmc   +2 more sources

Clonal disorders of clinical significance. A concept with important therapeutic implications. [PDF]

J Eur Acad Dermatol Venereol
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 891-892, May 2025.
Lipsker D.
europepmc   +2 more sources

An unusual case of granulomatous scleromyxedema [PDF]

JAAD Case Reports, 2022
Lauren Michelle, BA, Sara Sabeti, BS, Katerina Yale, MD, Brittany Urso, MD, Bonnie Lee, MD, Janellen Smith, MD   +5 more
doaj   +2 more sources

Successful treatment of scleromyxedema with dupilumab: A case report [PDF]

JAAD Case Reports
Abdulelah Alghamdi, MBBS, Abdulrahman Alfawzan, MBBS, Khalid Aburas, MBBS, Nedhal Ayoub, MD, Mohammad Almohideb, MD   +4 more
doaj   +2 more sources

Paraneoplastic atypical scleromyxedema with advanced gastric cancer

JAAD Case Reports, 2017
Se Jin Oh, MD, Seung Hwan Oh, MD, Ji-Young Jun, MD, Ji-Hye Park, MD, Jong Hee Lee, MD, PhD, Dong-Youn Lee, MD, PhD, Joo-Heung Lee, MD, PhD, Jun-Mo Yang, MD, PhD   +7 more
doaj   +3 more sources